Dosoki, Heba <br/><br/>
Targeting of NADPH oxidase in vitro and in vivo suppresses fibroblast activation and experimental skin fibrosis.  [electronic resource] 

 -  Experimental dermatology  01 2017 
 - 73-81 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1600-0625 
<br/><br/><label>Standard No.: </label>10.1111/exd.13180  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Actins--genetics<br/>Adult<br/>Animals<br/>Cells, Cultured<br/>Collagen Type I--genetics<br/>Collagen Type I, alpha 1 Chain<br/>Computer Simulation<br/>Cytokines--genetics<br/>Disease Models, Animal<br/>Enzyme Inhibitors--pharmacology<br/>Female<br/>Fibroblasts--enzymology<br/>Fibronectins<br/>Fibrosis<br/>Gene Expression--drug effects<br/>Gene Expression Profiling<br/>Gene Silencing<br/>Humans<br/>Infant, Newborn<br/>Isoenzymes--genetics<br/>Male<br/>Mice<br/>Middle Aged<br/>Multienzyme Complexes--metabolism<br/>Myofibroblasts<br/>NADH, NADPH Oxidoreductases--metabolism<br/>NADPH Oxidase 1--genetics<br/>NADPH Oxidase 2--genetics<br/>NADPH Oxidase 4--genetics<br/>Onium Compounds--pharmacology<br/>Primary Cell Culture<br/>RNA, Messenger--metabolism<br/>Scleroderma, Systemic--chemically induced<br/>Skin--enzymology<br/>Transforming Growth Factor beta--pharmacology<br/>Young Adult